Ionis Pharmaceuticals Reaches Oversold Status

Avatar photo

Legendary investor Warren Buffett’s advice on market behavior is highlighted as shares of Ionis Pharmaceuticals Inc (Symbol: IONS) hit an oversold level with an RSI reading of 26.3 during trading on Friday. The stock changed hands as low as $58.20 per share, marking a significant drop from its 52-week high of $86.74.

The current RSI reading of the S&P 500 ETF (SPY) stands at 58.1, suggesting that heavy selling for IONS may be nearing exhaustion, potentially creating buying opportunities for investors. IONS’s 52-week low is $40.03, and the last trade closed at $58.25.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

The free Daily Market Overview 250k traders and investors are reading

Read Now